MCK-17747-72086
2 vaccinations
1 coded response
20 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 441 / OH
- Registered
- 2021-03-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-11
Dose 1 — Pfizer-BioNTech
-
2021-03-15
Registered in v-safe
- 2021-03-15
- 2021-03-16
- 2021-03-20
- 2021-03-25
-
2021-04-01
Dose 2 — Pfizer-BioNTech
-
2021-04-01
Survey response — 0 day, dose 2MedDRA: Muscular weakness — Feeling: Good · Site: Pain · Muscle or body achesMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-04-02
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-08
-
2021-04-13
Pregnancy registry surveyPregnant at time of vaccination · No, please do not contact me
- 2021-04-15
- 2021-04-22
- 2021-04-29
- 2021-05-06
- 2021-05-13
- 2021-07-03
- 2021-09-30
- 2022-04-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-11 | Pfizer-BioNTech | |
| 2 | 2021-04-01 | Pfizer-BioNTech |
Free text
Release 6
Systemic reaction (other): Slight muscle weakness
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Muscular weakness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release